Purchases and Sales Made in Q3 2024 in Arvinas, Inc. (ARVN)
This table provides information about the institutional ownership of Arvinas, Inc. (ARVN) during Q3 2024. The information is specifically focused on institutions that hold shares of ARVINAS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2024
Q3 2024
|
Gilder Gagnon Howe & CO LLC
New York, NY |
SELL
|
- |
-90.8K- 31.83% |
$2.15M - $2.97M
|
194K
$1.27M
|
|
|
Nov 14, 2024
Q3 2024
|
Paradigm Biocapital Advisors LP
New York, NY |
SELL
|
- |
-98.2K- 4.03% |
$2.32M - $3.21M
|
2.34M
$15.2M
|
|
|
Nov 13, 2024
Q3 2024
|
Rhenman & Partners Asset Management Ab
Stockholm, V7 |
SELL
|
- |
-99.5K- 43.26% |
$2.35M - $3.26M
|
131K
$850K
|
|
|
Nov 13, 2024
Q3 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-131K- 47.57% |
$3.1M - $4.29M
|
144K
$940K
|
|
|
Nov 14, 2024
Q3 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-135K- 3.39% |
$3.2M - $4.42M
|
3.85M
$25.1M
|
|
|
Nov 14, 2024
Q3 2024
|
Vr Adviser, LLC
New York, NY |
SELL
|
- |
-173K- 27.61% |
$4.1M - $5.67M
|
454K
$2.96M
|
|
|
Nov 14, 2024
Q3 2024
|
Rtw Investments, LP
New York, NY |
SELL
|
- |
-186K- 6.25% |
$4.39M - $6.07M
|
2.78M
$18.1M
|
|
|
Nov 13, 2024
Q3 2024
|
Amundi
Paris, I0 |
SELL
|
- |
-186K- 96.14% |
$4.41M - $6.09M
|
7.48K
$48.7K
|
|
|
Nov 14, 2024
Q3 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-187K- 83.45% |
$4.43M - $6.13M
|
37.1K
$242K
|
|
|
Nov 14, 2024
Q3 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-257K- 32.98% |
$6.09M - $8.42M
|
523K
$3.4M
|
|
|
May 14, 2025
Q3 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-257K- 32.98% |
$6.09M - $8.42M
|
523K
$3.4M
|
|
|
Nov 14, 2024
Q3 2024
|
Commodore Capital LP
New York, NY |
SELL
|
- |
-684K- 36.32% |
$16.2M - $22.4M
|
1.2M
$7.81M
|
|
|
Nov 14, 2024
Q3 2024
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-1.49M- 49.9% |
$35.3M - $48.8M
|
1.5M
$9.75M
|